157 related articles for article (PubMed ID: 1691522)
21. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
22. Activation of capsaicin-sensitive sensory fibers modulates PAF-induced bronchial hyperresponsiveness in anesthetized guinea pigs.
Perretti F; Manzini S
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):927-31. PubMed ID: 7692777
[TBL] [Abstract][Full Text] [Related]
23. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
[TBL] [Abstract][Full Text] [Related]
24. Bombesin-induced bronchoconstriction in the guinea pig: mode of action.
Belvisi MG; Stretton CD; Barnes PJ
J Pharmacol Exp Ther; 1991 Jul; 258(1):36-41. PubMed ID: 2072308
[TBL] [Abstract][Full Text] [Related]
25. The effects of hetrazepine PAF antagonists in preclinical models of asthma.
Heuer HO
Agents Actions Suppl; 1991; 34():229-45. PubMed ID: 1793067
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological profile of UK-74,505, a novel and selective PAF antagonist with potent and prolonged oral activity.
Parry MJ; Alabaster VA; Cheeseman HE; Cooper K; deSouza RN; Keir RF
J Lipid Mediat Cell Signal; 1994 Sep; 10(3):251-68. PubMed ID: 7812676
[TBL] [Abstract][Full Text] [Related]
27. Activity of a novel thienodiazepine derivative as a platelet-activating factor antagonist in guinea pig lungs. Effects on platelet-activating factor and allergen induced eosinophil accumulation.
Tsunoda H; Sakuma Y; Shirato M; Obaishi H; Harada K; Yamada K; Shimomura N; Machida Y; Yamatsu I; Katayama K
Arzneimittelforschung; 1991 Mar; 41(3):224-7. PubMed ID: 1867658
[TBL] [Abstract][Full Text] [Related]
28. Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.
Yukawa T; Kroegel C; Evans P; Fukuda T; Chung KF; Barnes PJ
Immunology; 1989 Sep; 68(1):140-3. PubMed ID: 2807369
[TBL] [Abstract][Full Text] [Related]
29. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
30. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
31. Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and endotoxin/tumor necrosis factor induced changes in mortality and intestinal transit velocity.
Heuer H
Prog Clin Biol Res; 1989; 308():919-24. PubMed ID: 2780739
[No Abstract] [Full Text] [Related]
32. [Involvement of platelet activating factor (PAF) in ovalbumin antigen-induced late asthmatic response and increase of airway hyperresponsiveness in a guinea pig experimental model of asthma].
Arima M; Yukawa T; Terashi Y; Sagara H; Makino S
Arerugi; 1991 Feb; 40(2):141-6. PubMed ID: 2069513
[TBL] [Abstract][Full Text] [Related]
33. [Bronchial hyperresponsiveness to histamine in guinea pig induced by intravenous administration of platelet activating factor].
Tsukagoshi H; Aoki S; Kurosawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1450-5. PubMed ID: 2290229
[TBL] [Abstract][Full Text] [Related]
34. [3H]WEB 2086 labels platelet activating factor receptors in guinea pig and human lung.
Dent G; Ukena D; Sybrecht GW; Barnes PJ
Eur J Pharmacol; 1989 Oct; 169(2-3):313-6. PubMed ID: 2553451
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the antagonist activity of the PAF antagonists RP 59227 and WEB 2086 on elicited guinea pig peritoneal macrophages. Evidence for variable affinities and kinetics.
Turner NC; Wood LJ
J Pharmacol Exp Ther; 1992 Sep; 262(3):1139-46. PubMed ID: 1326625
[TBL] [Abstract][Full Text] [Related]
36. Platelet activating factor and histamine effects in synovial blood flow evaluated by laser-Doppler flowmetry.
Rocha FA; Jancar S; Fraga CA; Timo-Iaria C; De Brum-Fernandes AJ
J Rheumatol; 1993 Aug; 20(8):1374-7. PubMed ID: 8230022
[TBL] [Abstract][Full Text] [Related]
37. Octylonium bromide, an antagonist of platelet-activating factor.
Subissi A; Del Monte M; Evangelista S; Santicioli P; Criscuoli M
Arch Int Pharmacodyn Ther; 1989; 302():255-67. PubMed ID: 2636821
[TBL] [Abstract][Full Text] [Related]
38. Relaxations of guinea-pig isolated trachea induced by platelet-activating factor are epithelial-dependent and are antagonised by WEB 2086.
Conroy DM; Samhoun MN; Piper PJ
Eur J Pharmacol; 1990 Sep; 186(2-3):315-8. PubMed ID: 2289533
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of airway narrowing caused by inhaled platelet-activating factor. Role of airway microvascular leakage.
Tokuyama K; Lötvall JO; Barnes PJ; Chung KF
Am Rev Respir Dis; 1991 Jun; 143(6):1345-9. PubMed ID: 2048823
[TBL] [Abstract][Full Text] [Related]
40. Bronchial and vascular effects of Paf in the rat isolated lung are completely blocked by WEB 2086, a novel specific Paf antagonist.
Casals-Stenzel J; Franke J; Friedrich T; Lichey J
Br J Pharmacol; 1987 Aug; 91(4):799-802. PubMed ID: 3664079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
